TrialBMC medicine2024

Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study.

Guorui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.